PRALATREXATE, (S)-
UNII 0892G4T376

Substance Identification & Data

This profile provides standardized clinical and technical data for Pralatrexate, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0892G4T376.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1320211-69-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0892G4T376

CAS Registry Number

1320211-69-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PRALATREXATE, (S)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H23N7O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OGSBUKJUDHAQEA-HOCLYGCPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

23230419

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C#CC[C@@H](Cc1cnc2c(c(N)nc(N)n2)n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pralatrexate, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

L-GLUTAMIC ACID, N-(4-((1S)-1-((2,4-DIAMINO-6-PTERIDINYL)METHYL)-3-BUTYNYL)BENZOYL)-

PRALATREXATE, (S)-

External Clinical & Regulatory Resources

Previous UNII0892508P5Q

Next UNII089658A12D